Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KY › Frankfort › NPI 1427095488
Hospital

Frankfort Hospital, INC.

Frankfort Hospital, INC. was paid $39.41M by Medicaid between Jan 2018 and Dec 2024, across 213 billing codes. Its largest line is 99284, emergency room visit (serious) — 24% of everything it billed.

33Billing provider infoFRANKFORT HOSPITAL, INC.
FRANKFORT, KY 40601
33aNPI1427095488assigned 05/31/2006
28Total paid$39.41M
24GClaims647,334
24DCodes billed213
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Kentucky

Rank by total paid#15 of 36
Median peer was paid$36.08M
This provider vs. median1.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018110,735$6.35M
2019103,068$6.03M
202086,163$5.13M
202188,928$5.77M
202286,850$5.44M
202392,496$5.60M
2024incomplete79,094$5.09M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 24% 37,185 29,727 $9.57M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 19% 36,140 31,026 $7.61M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.4% 6,380 4,756 $2.53M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5.7% 24,157 18,270 $2.24M
74177 Computed tomography, abdomen and pelvis; with contrast material 5.2% 7,961 6,442 $2.04M
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.5% 9,568 8,671 $1.38M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.7% 16,705 4,792 $1.07M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.8% 11,552 4,101 $710K
71045 Radiologic examination, chest; single view 1.7% 19,616 14,566 $668K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.6% 16,276 4,917 $630K
70450 Computed tomography, head or brain; without contrast material 1.6% 6,689 5,133 $628K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.6% 3,906 3,018 $626K
201 more codes
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.2% 1,701 $491K
96375 Therapeutic injection; each additional sequential IV push 1.1% 8,495 $441K
71275 Computed tomographic angiography, chest, with contrast material 1.1% 2,146 $428K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.1% 5,990 $423K
G0378 Hospital observation service, per hour 1.1% 2,854 $418K
80053 Comprehensive metabolic panel <1% 59,062 $378K
G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 2,462 $373K
71046 Radiologic examination, chest; 2 views <1% 5,285 $310K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 2,972 $274K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,416 $270K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,808 $241K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 17,488 $232K
85027 <1% 48,003 $214K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,776 $200K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 5,406 $179K
72125 Computed tomography, cervical spine; without contrast material <1% 2,093 $157K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 3,479 $154K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,985 $145K
81001 <1% 25,223 $143K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,127 $135K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 7,106 $132K
97162 <1% 1,911 $122K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 815 $118K
93971 <1% 1,245 $115K
73630 <1% 2,280 $110K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 182 $98K
80048 Basic metabolic panel (calcium, ionized) <1% 20,149 $97K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 132 $94K
73030 <1% 2,215 $92K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 188 $89K
73610 <1% 2,184 $84K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 8,983 $80K
81025 <1% 9,081 $76K
80322 <1% 2,541 $74K
83880 <1% 4,652 $72K
73130 <1% 1,673 $72K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 231 $70K
84484 <1% 11,086 $68K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 721 $65K
73562 <1% 1,527 $65K
71250 <1% 720 $63K
72100 <1% 1,375 $62K
76830 Ultrasound, transvaginal <1% 492 $61K
84443 Thyroid stimulating hormone (TSH) <1% 4,968 $60K
12001 <1% 613 $58K
96361 Intravenous infusion, hydration; each additional hour <1% 4,086 $56K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,887 $52K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 162 $51K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,370 $51K
72110 <1% 503 $51K
88304 <1% 655 $49K
83690 <1% 13,979 $49K
73564 <1% 845 $47K
73110 <1% 1,151 $45K
74018 <1% 1,797 $45K
97163 <1% 928 $45K
72131 <1% 576 $42K
70496 <1% 156 $40K
87086 Culture, bacterial; quantitative colony count, urine <1% 8,453 $40K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 455 $40K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 112 $39K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,463 $38K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 4,356 $36K
70486 <1% 333 $35K
87430 <1% 4,914 $34K
80061 Lipid panel <1% 3,419 $32K
96376 <1% 1,479 $32K
70498 <1% 175 $32K
72170 <1% 1,112 $31K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 678 $31K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,275 $29K
73502 <1% 598 $29K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,280 $29K
85730 <1% 2,861 $29K
85610 <1% 7,396 $28K
74019 <1% 357 $27K
76642 <1% 514 $25K
83605 <1% 4,969 $25K
87040 <1% 2,652 $25K
80076 <1% 5,980 $23K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,969 $23K
80047 <1% 3,669 $23K
83735 <1% 6,511 $22K
84702 <1% 2,976 $22K
93975 <1% 179 $22K
80074 <1% 589 $19K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 598 $19K
92526 <1% 379 $19K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,042 $19K
97597 <1% 405 $18K
12011 <1% 175 $18K
82607 <1% 1,470 $17K
73590 <1% 355 $16K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 46 $15K
83036 Hemoglobin; glycosylated (A1C) <1% 2,622 $15K
87081 <1% 4,449 $14K
82728 <1% 1,309 $14K
84703 <1% 3,712 $14K
73080 <1% 364 $13K
97032 <1% 447 $13K
85378 <1% 2,140 $12K
72128 <1% 208 $12K
87077 <1% 2,410 $11K
82746 <1% 959 $11K
80331 <1% 556 $11K
80329 <1% 655 $10K
82550 <1% 2,903 $10K
86171 <1% 1,900 $10K
87186 <1% 1,336 $9K
82803 <1% 853 $9K
86850 <1% 1,746 $9K
83550 <1% 1,223 $9K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 46 $9K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 318 $9K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 754 $8K
81000 <1% 2,186 $8K
83540 <1% 1,399 $7K
84439 <1% 900 $7K
94644 <1% 332 $7K
10060 <1% 45 $7K
87522 Neg quan hep c or qual rna <1% 160 $7K
97166 <1% 119 $6K
43450 <1% 34 $6K
72040 <1% 159 $6K
86900 <1% 2,791 $6K
86901 <1% 2,776 $5K
73090 <1% 171 $5K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 44 $5K
J7030 Infusion, normal saline solution , 1000 cc <1% 1,559 $5K
76857 <1% 106 $5K
78227 <1% 40 $5K
76770 <1% 53 $5K
87070 <1% 1,023 $5K
94060 <1% 72 $5K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 17 $4K
82553 <1% 432 $3K
94729 <1% 161 $3K
81003 <1% 488 $3K
86701 <1% 289 $3K
97161 <1% 43 $3K
86140 <1% 849 $3K
77066 Tomosynthesis, mammo <1% 32 $3K
85651 <1% 625 $2K
76536 <1% 14 $2K
87205 <1% 467 $2K
76870 <1% 37 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 256 $2K
84100 <1% 765 $2K
71101 <1% 48 $2K
97167 <1% 25 $2K
C1769 Guide wire <1% 14 $2K
99213 Doctor's office visit, returning patient (routine) <1% 56 $2K
82150 <1% 291 $1K
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries <1% 16 $1K
73521 <1% 17 $1K
86308 <1% 331 $1K
93976 <1% 12 $1K
94726 <1% 40 $979.95
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 13 $964.47
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 15 $948.60
84550 <1% 397 $928.69
77065 Tomosynthesis, mammo <1% 16 $770.68
87210 <1% 174 $614.90
84425 <1% 47 $452.19
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 37 $451.87
82248 <1% 237 $402.35
82784 <1% 26 $384.70
86593 <1% 70 $346.56
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 17 $332.85
29125 <1% 15 $316.15
80069 <1% 101 $305.38
83516 <1% 14 $269.77
88300 <1% 12 $212.23
83615 <1% 59 $203.02
86255 <1% 14 $198.05
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 658 $171.94
86922 <1% 16 $171.69
82272 <1% 57 $149.19
87340 <1% 14 $131.80
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 259 $128.85
82947 <1% 49 $124.74
86706 <1% 12 $115.74
93356 <1% 242 $93.62
84460 <1% 30 $86.87
84132 <1% 30 $61.49
J7120 Ringers lactate infusion, up to 1000 cc <1% 413 $59.60
82140 <1% 15 $54.15
84450 <1% 14 $52.23
84156 <1% 36 $45.14
82009 <1% 15 $39.38
82565 <1% 16 $32.88
36600 <1% 19 $31.30
85014 <1% 21 $14.22
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 58 $9.19
J3010 Injection, fentanyl citrate, 0.1 mg <1% 188 $3.37
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 51 $0.73
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 15 $0.18
J2704 Injection, propofol, 10 mg 0% 164 $0.00
A9270 Non-covered item or service 0% 153 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 0% 18 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 0% 38 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHANKINS, SPENCER (CFO)